Titlebook: Intellectual Property Issues; Therapeutics, Vaccin Ulrich Storz,Wolfgang Flasche,Johanna Driehaus Book 2012 The Author(s) 2012 Disease-gene

tolerance

inchoate

IP Issues of Therapeutic Antibodies,he broadest scope of protection, other ways of follow-up protection should be considered by innovators to achieve as long protection as possible. Further, in case a theoretical antibody against a given target is already prior art, innovators should be aware of methods to create compound protection f

orient

nettle

deactivate

2192-9904 rts?.Includes supplementary material: .SpringerBriefs in Biotech Patents present timely reports of intellectual properties (IP) issues and patent aspects in the field of biotechnology. This new volume in the series focuses on the particular IP issues of therapeutics, vaccines and molecular diagnosti

懶洋洋

控制

Book 2012 technologies and compounds used therein. The third chapter gives a broad overview of areas of law that are particularly relevant to the patenting of peptide vaccines and therapeutic peptides as products and in compositions. The scope of patentable subject matter is discussed, as it has been the focus of much wrangling and debate in the courts..

GLOOM

gimmick

一罵死割除

SpringerBriefs in Biotech Patentshttp://image.papertrans.cn/i/image/469201.jpg